Colonial Trust Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Colonial Trust Advisors's ELV Position: Q3 2026 in Review
Colonial Trust Advisors reduced its Elevance Health (ELV) stake by 15% in Q3 2026, selling an estimated $14.4K and leaving 200 shares worth $77.8K. The position accounts for 0.01% of the portfolio, ranked #318.
Colonial Trust Advisors first reported a position in ELV in Q3 2022 and has held it in 17 quarters since. The position peaked at $222K in Q4 2022. 1,626 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Colonial Trust Advisors held 200 shares of Elevance Health worth $77.8K as of Q3 2026.
- Colonial Trust Advisors sold 36 Elevance Health shares in Q3 2026, an estimated $14.4K.
- Elevance Health made up 0.01% of Colonial Trust Advisors's portfolio in Q3 2026, its #318 holding.
- Colonial Trust Advisors first reported a position in Elevance Health in Q3 2022 and has held it in 17 quarters since.
- Colonial Trust Advisors's Elevance Health position peaked at $222K in Q4 2022.
- 1,626 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Colonial Trust Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.